Objective:To discuss the cause for the increase in the rate of caesarean sections and the key for its reduction. Methods:Retrospectively determine the changes in the rate and indications of Caesarean sections in the past fourteen years in our hospital. Results:Between 1992 and 1996,the rate of Caesarean sections was relatively stable,averaging 26.013%. It rose above 30% in 1997,and increased to 57.12% in 2002. Post 2004,societal factors were controlled,and the incidence decreased to 54.71%,and to 49.74% in 2006. Conclusion:Societal factors and over diagnosis are important contributors to the rise in the rate of Caesarean sections. Reinforcing pregnancy education and our understanding of their indications are key for reducing the rate of Caesarean sections.

目前,腹腔镜下子宫切除术式主要有腹腔镜辅助阴式子宫切除术(laparoscopically assisted vaginal hysterectomy, LAVH),腹腔镜鞘膜内子宫切除术(laparoscopically introfasial subtotal hysterectomy,LISH),腹腔镜子宫次全切除术(laparoscopically subtotal hysterectomy,LSH)和腹腔镜全子宫切除术(laparoscopically total hysterectomy,LTH).

对宫颈光滑鳞状细胞癌1例分析如下. 1 病历摘要 女,37岁.孕2产1活1流1,离异8 a,近8 a无性生活.患者既往月经规律,3～7 d/30～40 d.末次月经2007-10-04,患者于2007-10-10体检时行TCT检查有非典型细胞(性质不明),来我院就诊.

Objective To assess the clinical curative effect of lansoprazole to treat the duodenal ulcer. Methods 47 cases of such patient were divided into 2 groups. 24 cases were treated with lansoprazole for 4 weeks and 23 cases were treated with ranitidine as control group. Results 21 cases was healed, 2 cases good effect, 1 case effect with healing rate of 95.8% in therapy group. 13 cases was healed, 2 cases good effect, 5 cases effect with healing rate of 62.5% in control group. Conclusion Lansoprazole is second generation of PPI that could treat duodeenal ulcer with strong inhibiting acid.

现就功能失调性子宫出血(简称功血)的诊断治疗简要综述如下. 1诊断 临床工作中,准确诊断功血并非易事,而误诊"功血"常有发生.防止误诊的方法首先是与有关易混淆的器质性疾病进行鉴别,应用必要和灵敏的诊断手段,分清无排卵型或有排卵型功血,以决定进一步治疗方案.

本文采用红汞加酒精经尿管膀胱注入治疗产后尿潴留,并与传统留置尿管方法进行比较,取得了满意效果,现报道如下:1 资料与方法1.1 资料来源:全部病例均来自我院住院期间产后尿潴留的患者.选择1999年1月～2000年10月的尿潴留患者40例为观察组;选择1997年1月～1998年12月的尿潴留患者36例为对照组.两组患者均无其它系统器质性疾病和产科并发症.